Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy is a research paper published in Allergy (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Alfred Research Trusts, Alfred Health
Grant: A11107
National Health and Medical Research Council
Grant: APP1107228
National Health and Medical Research Council
Grant: APP1005298
National Institutes of Health
Grant: U19 AI125378‐01
NIH HHS
Grant: U19 AI125378-01
MeSH Terms
Keywords